Skip to content

Study on the influence and mechanism of gut microbiota dysbiosis on depression through enterochromaffin cells

Study on the influence and mechanism of gut microbiota dysbiosis on depression through enterochromaffin cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083767
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Observation group:none
Control group:none

Sponsors

The First Hospital Of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Criteria for the observation group: (1) Meets the diagnostic criteria for major depressive disorder in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); (2) Untreated at the onset; (3) Ages between 18 and 50 years old; (4) Total score on the Hamilton Rating Scale for Depression (HAMD-24) > 20 points; (5) Voluntary participation in this study and signing of written informed consent. Criteria for the control group: (1) No history of psychiatric disorders; (2) HAMD-24 scores consistently less than 7 points; (3) Ages between 18 and 50 years old.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the observation group: (1) Presence of other mental disorders such as schizophrenia, anxiety disorders, etc.; (2) Presence of other physical illnesses, including cardiovascular diseases, endocrine system diseases, oral diseases, especially gastrointestinal diseases such as inflammatory bowel disease, peptic ulcer, irritable bowel syndrome, etc.; (3) Severe suicidal tendencies; (4) Evidence of alcohol or other substance dependence or abuse; (5) Family history: Family history of mood disorders, schizophrenia, and other psychiatric illnesses; (6) Treatment history: Received treatment with antibiotics, probiotics, immunosuppressants, etc., in the past month; (7) Reproductive history: Pregnant or lactating women; (8) Participation in a clinical trial in the past 90 days or participation in two or more clinical trials in the past year. The exclusion criteria for the control group are consistent with those of the observation group.

Design outcomes

Primary

MeasureTime frame
Enterochromaffin cells;Gut microbiota;

Secondary

MeasureTime frame
blood indicators,such as IL-1,TNF-a,CRP;

Countries

China

Contacts

Public ContactLiu Penghong

The First Hospital Of Shanxi Medical University

liupenghong6@163.com+86 188 3418 0209

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026